BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32840699)

  • 21. Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort.
    Budhu JA; Chukwueke UN; Jackson S; Lee EQ; McFaline-Figueroa JR; Willmarth N; Dalmage M; Kawachi I; Arons D; Chang SM; Galanis E; Hervey-Jumper SL; Wen PY; Porter AB
    Neuro Oncol; 2024 Apr; 26(4):596-608. PubMed ID: 38071654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).
    Freedman RA; Dockter TJ; Lafky JM; Hurria A; Muss HJ; Cohen HJ; Jatoi A; Kemeny MM; Ruddy KJ
    Oncologist; 2018 Sep; 23(9):1016-1023. PubMed ID: 29674441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
    Newman LA; Lee CT; Parekh LP; Stewart AK; Thomas CR; Beltran RA; Lucci A; Green B; Ota D; Nelson H;
    Cancer; 2006 Jan; 106(1):188-95. PubMed ID: 16333856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An institutional strategy to increase minority recruitment to therapeutic trials.
    Anwuri VV; Hall LE; Mathews K; Springer BC; Tappenden JR; Farria DM; Jackson S; Goodman MS; Eberlein TJ; Colditz GA
    Cancer Causes Control; 2013 Oct; 24(10):1797-809. PubMed ID: 23846282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
    Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA
    J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reporting results in U.S. clinical trials for obstructive sleep apnea and insomnia: How transparent are they?
    He Z; Wallace DM; Barnes A; Tang X; Jean-Louis G; Williams NJ
    Sleep Health; 2020 Aug; 6(4):529-533. PubMed ID: 32179065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women.
    Hoskins KF; Danciu OC; Ko NY; Calip GS
    JAMA Oncol; 2021 Mar; 7(3):370-378. PubMed ID: 33475714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology.
    Hirko KA; Rocque G; Reasor E; Taye A; Daly A; Cutress RI; Copson ER; Lee DW; Lee KH; Im SA; Park YH
    BMC Med; 2022 Feb; 20(1):72. PubMed ID: 35151316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demographic and Health Behavior Factors Associated With Clinical Trial Invitation and Participation in the United States.
    Williams CP; Senft Everson N; Shelburne N; Norton WE
    JAMA Netw Open; 2021 Sep; 4(9):e2127792. PubMed ID: 34586365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reporting of race and ethnicity in breast cancer research: room for improvement.
    Mitchell KW; Carey LA; Peppercorn J
    Breast Cancer Res Treat; 2009 Dec; 118(3):511-7. PubMed ID: 19444602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility trial of a Spanish-language multimedia educational intervention.
    Wells KJ; McIntyre J; Gonzalez LE; Lee JH; Fisher KJ; Jacobsen PB; Meade C; Muñoz-Antonia T; Quinn GP
    Clin Trials; 2013 Oct; 10(5):767-74. PubMed ID: 23935161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.
    McKay RR; Gold T; Zarif JC; Chowdhury-Paulino IM; Friedant A; Gerke T; Grant M; Hawthorne K; Heath E; Huang FW; Jackson MD; Mahal B; Ogbeide O; Paich K; Ragin C; Rencsok EM; Simmons S; Yates C; Vinson J; Kantoff PW; George DJ; Mucci LA
    JCO Glob Oncol; 2021 Apr; 7():495-505. PubMed ID: 33835826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association.
    McCaskill-Stevens W; Pinto H; Marcus AC; Comis R; Morgan R; Plomer K; Schoentgen S
    J Clin Oncol; 1999 Mar; 17(3):1029-39. PubMed ID: 10071298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.
    Lalonde CS; Switchenko JM; Behera M; Bilen MA; Owonikoko TK; Kaufman JL; Nooka AK; Lewis CM; Hitron E; Collins H; Judson EC; Alese OB; Donald Harvey R; Carlisle JW
    Oncologist; 2023 Dec; 28(12):1055-1063. PubMed ID: 37418599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographic and Socioeconomic Disparities Among Cancer Survivors in Clinical Trials Participation, USA, 2016-2018.
    Parekh T; Desai A
    J Cancer Educ; 2022 Feb; 37(1):88-90. PubMed ID: 32529604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
    Paul K; Sathianathen N; Dahm P; Le C; Konety BR
    J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.